Bettina specialises in molecular biology, currently focusing on mRNA-based cancer therapeutics.
Bettina is developing mRNA platform technologies to target “undruggable” proteins. Bettina holds a Bachelor of Science in Molecular Biotechnology (TUM) and a Master of Medical Biotechnology (UQ), receiving the SCMB Postgraduate Coursework Prize. During her masters, Bettina joined the laboratory of Dr Seth Cheetham for projects on targeted lipid nanoparticle delivery and chimeric antigen receptor (CAR) design. With a background in microbiology, she has previoulsy worked on rapid testing devices for blood infections and SARS-CoV-2.